Search

Author/Creator Pellen, Daniel

3. S33. REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION. (9th April 2019)

Authors:
Weickert, Thomas; Jacomb, Isabella; Lenroot, Rhoshel; Lappin, Julia; Weinberg, Danielle; Brooks, William; Brown, David; Pellen, Daniel; Kindler, Jochen; Mohan, Adith; Wakefield, Denis; Lloyd, Andrew; Stanton, Clive; O'Donnell, Maryanne; Liu, Dennis; Galletly, Cherrie; Weickert, Cynthia Shannon
Journal:
Schizophrenia bulletin
Issue:
Volume 45(2019)Supplement 2
Page Start:
S318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The value of early intervention in creating the new mental health system: Response to Allison et al. (July 2020)

Authors:
Chanen, Andrew; Yung, Alison; Killackey, Eoin; Hickie, Ian; Coghill, David; Scott, James G; Scott, Elizabeth; Denborough, Paul; Dixon, Lisa; Fisher, Leeanne; Kane, John; Malla, Ashok; Nordentoft, Merete; Pellen, Daniel; Radovini, Alessandra; McGorry, Patrick
Journal:
Australian and New Zealand journal of psychiatry
Issue:
Volume 54:Number 7(2020)
Page Start:
667
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗